Semax (ACTH 4-7 Pro₈Gly₉Pro₁₀) — heptapeptide amino acid sequence · MW 887.02 g/mol · C₃₇H₅₁N₉O₁₀S
What Is Semax?
A synthetic neuropeptide that dramatically upregulates BDNF — the protein your brain uses to build new neural connections and protect existing ones.
Semax is a synthetic heptapeptide derived from a fragment of ACTH (adrenocorticotropic hormone) — specifically the 4-7 sequence, modified with a Pro-Gly-Pro extension to increase stability and CNS penetrance. It was developed at the Institute of Molecular Genetics in Russia, where it has been approved as a prescription medication for stroke recovery, cognitive impairment, and neuroprotection since the 1990s.
What makes Semax extraordinary in the peptide space is its effect on BDNF — Brain-Derived Neurotrophic Factor. BDNF is the primary protein your brain uses to form new neural connections, protect existing neurons from damage, and support learning, memory, and mood regulation. Studies have shown Semax can upregulate BDNF expression by up to 800% — a magnitude of effect that no other peptide or supplement comes close to matching.
Unlike stimulants — which force neurochemical release and leave you depleted — Semax works by building the infrastructure for better cognition. It doesn't push harder on a tired system. It repairs and upgrades the system itself.
Stimulants like Adderall and modafinil increase dopamine and norepinephrine availability — borrowing from tomorrow to perform today. Semax works differently: it upregulates BDNF and supports neuroplasticity at the structural level. The result is cognitive improvement that builds over time rather than depleting over time.
How Does Semax Work?
Four distinct mechanisms explain Semax's broad cognitive and neuroprotective effects.
Semax dramatically increases the expression of BDNF — the primary growth factor for neurons. BDNF supports neuroplasticity, strengthens synaptic connections, promotes neurogenesis, and protects existing neurons from oxidative damage and excitotoxicity.
Semax modulates dopaminergic and serotonergic systems — increasing the efficiency of neurotransmitter signaling without the receptor downregulation that follows stimulant use. This contributes to focus, motivation, and mood-lifting effects without the crash or tolerance of traditional nootropics.
Semax reduces neuroinflammation and provides direct neuroprotective effects — particularly relevant in stroke recovery, traumatic brain injury, and the chronic neuroinflammation that accumulates with age. It has demonstrated ability to reduce ischemic brain lesion size in stroke models.
Administered nasally, Semax is absorbed through the olfactory epithelium and travels directly to the CNS along olfactory nerve pathways — bypassing the blood-brain barrier entirely. Effect onset is approximately 15 minutes.
How Nasal Semax Reaches the Brain
The olfactory route bypasses the blood-brain barrier — delivering Semax directly to CNS tissue in ~15 minutes.
Semax, N-Acetyl Semax & Semax Amidate — What's the Difference?
Three variants with meaningfully different potency and duration profiles.
| Variant | Modification | Potency | Duration | Best For |
|---|---|---|---|---|
| Semax | Base compound | Standard | 4–6 hours | First-time users, daily maintenance Start Here |
| N-Acetyl Semax | N-acetyl group added | Higher | 6–8 hours | Experienced users wanting longer effect |
| Semax Amidate | C-terminal amidation | Highest | 8–12 hours | Maximum potency — lower dose needed |
Start with standard Semax at the lowest effective dose to assess your response. N-Acetyl Semax and Semax Amidate are meaningfully more potent — titrate up slowly and adjust dose downward when switching variants.
What Is Semax Used For?
From daily cognitive performance to neuroprotection and recovery.
- Focus & Cognitive PerformanceUsers consistently report improved focus, faster processing speed, better working memory, and mental clarity described as "cleaner" than stimulants — without anxiety or crash.
- BDNF-Driven NeuroplasticitySemax's BDNF upregulation creates a neuroplasticity window that makes the brain more receptive to forming new connections — ideal during periods of intense learning or skill acquisition.
- Anxiety Reduction & Mood SupportThrough serotonergic modulation and neuroinflammation reduction, Semax has demonstrated anxiolytic effects — particularly relevant for anxiety-driven cognitive impairment.
- Stroke Recovery & NeuroprotectionThe primary clinical application in Russia. Semax reduces ischemic brain damage, supports neural repair post-stroke, and has shown neuroprotective effects in traumatic brain injury models.
- ADHD-Type PresentationsGrowing clinical interest for ADHD-adjacent presentations — particularly where root causes involve neuroinflammation, reduced neuroplasticity, or dopaminergic inefficiency.
- Age-Related Cognitive Decline PreventionBDNF levels decline with age. Semax's BDNF upregulation is directly relevant to any longevity protocol targeting cognitive preservation.
How to Use Semax
Three distinct protocols matched to different goals and experience levels.
Semax has mild stimulant properties in some users. Start at the lowest dose (100–200mcg) and assess your individual response before escalating. Some users experience anxiety or overstimulation at higher doses — particularly with the amidate variant. Do not combine with MAO inhibitors. Consult a physician before use if you have a history of seizures, bipolar disorder, or are taking psychiatric medications.
Semax in a Cognitive Longevity Stack
Semax anchors the cognitive performance layer of a complete longevity stack.
- +Semax + NAD+ — The most powerful cognitive longevity combination. NAD+ restores mitochondrial energy production; Semax upregulates BDNF and neuroplasticity. Together they address cognitive performance from the energy substrate (NAD+) and growth factor (BDNF) angles simultaneously.
- +Semax + Epithalon — Semax drives cognitive performance; Epithalon handles deep sleep architecture that consolidates the neuroplastic changes Semax initiates. Memory consolidation and BDNF-driven rewiring happen primarily during slow-wave sleep.
- +Semax + BPC-157 — BPC-157 reduces systemic neuroinflammation via the gut-brain axis. Combined with Semax's direct neuroprotective effects, this stack addresses cognitive impairment from both the inflammatory and neuroplasticity angles.
- +Semax + 5-Amino-1MQ — 5-Amino-1MQ preserves NAD+ via NNMT inhibition; Semax drives BDNF and neuroplasticity. A strong combination for anyone over 40 experiencing cognitive slowing alongside metabolic changes.
Frequently Asked Questions
Acute effects — improved focus, mental clarity, mild mood lift — are typically noticeable within 15–30 minutes of nasal administration. Longer-term neuroplasticity and BDNF-driven benefits accumulate over 4–8 weeks of consistent use.
Semax is not FDA-approved in the United States and exists in a regulatory gray area — neither scheduled nor approved. Available through compounding pharmacies as a research compound and increasingly prescribed off-label by functional medicine practitioners. It is an approved prescription medication in Russia.
Unlike stimulant medications, Semax does not appear to cause dependency or significant tolerance with standard cycling protocols. Most practitioners recommend 4–8 week courses with break periods.
Both are Russian-developed neuropeptides administered nasally — but with different profiles. Semax is more stimulating and cognitively activating with stronger BDNF upregulation. Selank is more anxiolytic and calming. Many practitioners use them together — Selank in the evening, Semax in the morning.
Look for: CoA confirming ≥98% purity by HPLC, correct pH-balanced nasal formulation (pH 4–6), clearly stated concentration per spray, cold-chain shipping. Avoid: no CoA available, unusually low pricing, pre-mixed solutions shipped at room temperature.
This page is for educational purposes only and does not constitute medical advice. Semax is an approved prescription medication in Russia and a research compound in the US and EU. Always consult a qualified, licensed healthcare provider before beginning any peptide protocol. InformedPeptides.com and its authors are not liable for actions taken based on the content of this page.
Anxiety & Depression — A Metabolic Reframe
New research is reframing anxiety and depression as metabolic conditions — not just neurochemical ones.
The dominant model of anxiety and depression — the serotonin/norepinephrine imbalance theory — has driven pharmaceutical treatment for decades. But it has significant limitations: roughly 30–40% of patients don't respond adequately to first-line antidepressants, and many who do respond experience incomplete remission with persistent cognitive and physical symptoms.
Emerging research — most prominently the work of Dr. Chris Palmer at Harvard, outlined in his book Brain Energy — is reframing anxiety and depression as metabolic and mitochondrial conditions. The brain consumes 20% of total body energy. When mitochondrial function declines — from chronic stress, poor sleep, inflammation, or aging — mood regulation is one of the first casualties.
Peptide therapy approaches this from a fundamentally different angle: rather than adjusting neurotransmitter levels, it targets the cellular energy infrastructure and neuroprotective mechanisms that make healthy mood regulation possible in the first place.
Dr. Chris Palmer's Brain Energy hypothesis proposes that mental illness is fundamentally a metabolic disorder — and that improving mitochondrial function is a more durable path to mood recovery than neurotransmitter manipulation alone. This framework directly supports the use of mitochondrial-targeted peptides like SS-31 and metabolic interventions like Selank and CAX in mood disorder protocols.
What's Driving Anxiety & Depression?
Four metabolic and neurological drivers — each addressable with targeted peptide interventions.
Reduced ATP production in neurons impairs the energy-intensive processes of neurotransmitter synthesis, synaptic signaling, and neuroplasticity. The brain simply cannot regulate mood effectively without adequate cellular energy — making mitochondrial support foundational to any mood protocol.
Chronic low-level inflammation crosses the blood-brain barrier, disrupting serotonin synthesis, impairing neuroplasticity, and activating the kynurenine pathway — which diverts tryptophan away from serotonin production toward neurotoxic metabolites. Neuroinflammation is now recognized as a primary driver of treatment-resistant depression.
Depression is associated with reduced BDNF (Brain-Derived Neurotrophic Factor) — the protein that supports neuron survival, growth, and the formation of new synaptic connections. Without adequate BDNF, the brain loses the structural flexibility needed for emotional regulation and recovery from stress.
Sleep is when the brain consolidates emotional memories, clears neurotoxic waste, and resets stress hormone levels. Disrupted deep sleep — which worsens with age and stress — amplifies both anxiety and depressive symptoms while impairing the overnight repair that mood regulation depends on.
Peptides for Anxiety & Depression
Five compounds addressing mood disorders from the metabolic and neuroprotective angle — with Selank and CAX as the anchors.
-
★ Anchor — Anxiety Selank (Selank) Selank is a neuroprotective peptide with particular efficacy for anxiety. Unlike benzodiazepines or SSRIs, it works through brain-specific neuroprotective signaling pathways rather than broad systemic sedation — delivering meaningful anxiety relief without dependency risk. Also supports BDNF expression and cognitive clarity. Available as nasal spray (most common) or subcutaneous injection. Effects on anxiety are typically noticeable within the first course.
-
★ Anchor — Depression & Mood CAX (Cortexin) CAX works synergistically with Selank to address mood disorders across the full spectrum — both the anxious and depressive dimensions. Where Selank is particularly strong on anxiety, CAX adds the mood-lifting and motivational component. Supports neuronal metabolism, reduces excitotoxicity, and has demonstrated neuroprotective effects in clinical settings. The Selank + CAX combination addresses both ends of the anxiety-depression spectrum more completely than either compound alone.
-
Sleep foundation — always indicated Epithalon Poor sleep is both a symptom and a driver of anxiety and depression. Epithalon restores deep sleep architecture through pineal gland support — creating the overnight recovery environment that mood regulation depends on. Also normalizes the growth hormone pulse that supports neuronal repair during sleep. Considered foundational in any mood-focused peptide protocol.
-
Mitochondrial energy support SS-31 (Elamipretide) Targets the inner mitochondrial membrane to reduce oxidative stress and improve ATP production at the neuronal level. Directly supports the metabolic foundation that Dr. Palmer's framework identifies as central to mood disorder recovery. Available as subcutaneous injection or nasal spray.
-
Gut-brain axis & inflammation BPC-157 The gut-brain axis is increasingly recognized as central to mood regulation — with gut inflammation directly affecting serotonin production and neuroinflammation. BPC-157 repairs gut lining integrity, reduces systemic inflammation, and works along the vagus nerve — the primary gut-brain communication pathway. Particularly relevant for mood disorders with a significant inflammatory component.
Combining peptides with psychiatric medications requires physician oversight. People currently taking SSRIs, SNRIs, MAOIs, antipsychotics, or mood stabilizers should not add peptide therapy without consulting their prescribing physician. Some peptide interactions — particularly with serotonergic medications — require careful management. This is not a barrier to exploration — but it requires proper supervision.
The Mood Protocol Stack
Each compound addresses a different layer of the mood disorder cascade.
Selank as the primary anchor — with Epithalon for sleep restoration. Add SS-31 if cognitive fog and fatigue accompany the anxiety. BPC-157 if gut symptoms or systemic inflammation are present.
CAX as the primary anchor — with Selank added for the neuroplasticity and cognitive clarity benefits. Epithalon always included for sleep. SS-31 for the mitochondrial energy foundation.
Selank + CAX together as the full anchor combination. This is the most common clinical presentation and the combination both compounds were designed to address together.
Selank and CAX effects on anxiety and mood often taper over 4–8 weeks post-course. Cycling protocols of 2–4 courses per year are commonly used for maintenance. Your provider should design a protocol matched to your response pattern.
Frequently Asked Questions
This requires physician oversight — particularly for SSRIs and SNRIs. Selank and CAX have low interaction risk with most antidepressants, but any change to a psychiatric medication regimen should be discussed with your prescribing physician. Some practitioners use peptides as a bridge during antidepressant tapering under close supervision.
Many people notice anxiety reduction from Sela nk within the first few days of a course. CAX's mood-lifting effects typically develop more gradually over 2–4 weeks. Sleep improvements from Epithalon are often the earliest and most noticeable change — with mood benefits following as sleep quality improves.
People with a history of bipolar disorder, psychosis, or other serious psychiatric conditions should approach peptide therapy with heightened caution and must have close physician oversight. Some interventions that improve energy and mood can theoretically shift mood states in ways that need monitoring. This is not a barrier to exploring peptide therapy — but it requires a provider who understands your full psychiatric history.
No. Peptide therapy works best as part of a comprehensive approach that includes appropriate psychotherapy, lifestyle foundations (sleep, exercise, nutrition), and medical supervision. It addresses the metabolic and neurological substrate that makes mood regulation possible — not the psychological and relational dimensions that therapy addresses. The most effective outcomes combine both.
Depression Peptide Guide
This guide is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Peptide therapy is not FDA-approved for anxiety or depression. Always consult a qualified, licensed healthcare provider before beginning any peptide protocol — especially if you are currently taking psychiatric medications. InformedPeptides.com and its authors are not liable for actions taken based on the content of this page.
Brain Fog & Cognitive Decline — An Energy Problem
The brain uses 20% of your body's energy while being only 10% of its mass. When mitochondria underperform, cognition is the first thing to suffer.
Brain fog and cognitive decline are increasingly understood as energy problems — not simply aging. The brain is the most metabolically demanding organ in the body, consuming approximately 20% of total ATP output despite representing only 10% of body weight. When mitochondrial function declines — as it consistently does with age, chronic inflammation, oxidative stress, and poor sleep — the brain is the first organ to feel it.
The result is the constellation of symptoms most people recognize as brain fog: difficulty concentrating, slow processing speed, poor short-term memory, mental fatigue, word-finding problems, and the persistent sense that your thinking is operating through a filter.
The good news is that for the metabolic and mitochondrial form of cognitive decline — which is the most common form in middle-aged adults — meaningful reversal of symptoms is frequently achievable when the protocol addresses the root cause rather than just the symptoms.
Brain fog is not a diagnosis — it's a symptom of mitochondrial underperformance. The therapeutic approach that works is not stimulants or nootropics that push harder on a depleted system. It's restoring the cellular energy infrastructure that makes clear thinking possible in the first place.
What's Actually Driving Brain Fog?
Four primary drivers — each addressable with targeted interventions.
The primary driver in most cases. Mitochondria in neurons become less efficient with age, chronic stress, and oxidative damage — producing less ATP and more reactive oxygen species. The result is a brain that can't generate the energy required for optimal cognition.
Chronic low-level inflammation — driven by poor diet, gut dysbiosis, omega-3 deficiency, and systemic inflammaging — crosses the blood-brain barrier and impairs neuronal function. Omega-3 deficiency is a particularly common and correctable contributor.
NAD+ is essential for neuronal energy production and DNA repair. Its 50% decline between ages 40 and 60 directly impairs the mitochondrial electron transport chain in brain cells — compounding the energy deficit that drives cognitive symptoms.
Deep sleep is when the brain clears metabolic waste via the glymphatic system and consolidates memory. Declining melatonin and growth hormone output with age disrupts this process — allowing neurotoxic proteins to accumulate and impairing memory consolidation.
The Cognitive Recovery Stack
Five compounds addressing the root causes of brain fog from different angles — with Methylene Blue as the anchor.
-
★ Anchor Compound — Not a peptide Methylene Blue Methylene Blue directly supports the mitochondrial electron transport chain — acting as an electron shuttle that bypasses dysfunctional complexes and restores ATP production. It produces measurable improvements in focus, processing speed, and cognitive clarity. At therapeutic doses it turns urine blue-green — expected and harmless. Critical warning: Methylene Blue has mild MAO inhibitor properties. It must not be combined with serotonergic medications (SSRIs, SNRIs, tramadol) without physician oversight due to serotonin syndrome risk.
-
Mitochondria-targeted peptide — injectable or nasal spray SS-31 (Elamipretide) A mitochondria-targeted peptide that concentrates at the inner mitochondrial membrane — reducing oxidative stress at the site of ATP production and improving mitochondrial efficiency. Available as subcutaneous injection or nasal spray. The nasal spray format provides direct CNS delivery, bypassing the blood-brain barrier for faster neurological effect.
-
Anxiolytic neuropeptide Selank (Selank) A synthetic analog of tuftsin with anxiolytic and nootropic properties. Reduces cognitive anxiety — the mental static that compounds brain fog — while supporting BDNF expression and neuroplasticity. Particularly effective for the brain fog presentation that includes anxiety, overwhelm, and difficulty filtering irrelevant information.
-
Cognitive enhancer CAX (Cortexin) A polypeptide nootropic derived from cortical brain tissue. Supports neuronal metabolism, reduces excitotoxicity, and has demonstrated neuroprotective effects in clinical settings. Works synergistically with Selank — Selank reduces anxiety-driven cognitive impairment while CAX supports the underlying neuronal metabolism.
-
Sleep foundation — always indicated Epithalon Deep sleep is when the brain clears neurotoxic waste via the glymphatic system. Without restorative sleep, no cognitive protocol works optimally. Epithalon restores deep sleep architecture through pineal gland support — making it the foundation on which all other cognitive interventions build.
Methylene Blue + Serotonergic Medications: Combining Methylene Blue with SSRIs, SNRIs, tramadol, or certain migraine medications can cause serotonin syndrome — a potentially serious condition. This combination requires physician oversight and is generally avoided. Always disclose all medications to your provider before starting any Methylene Blue protocol.
The Omega Index — Test Before You Treat
94% of Americans are omega-3 deficient. Neuroinflammation from omega-3 deficiency is one of the most correctable contributors to brain fog.
Before starting any cognitive peptide protocol, the Omega Index is the single most important test to run. The Omega Index measures the percentage of EPA and DHA omega-3 fatty acids in red blood cell membranes — a more accurate reflection of long-term omega-3 status than blood plasma levels.
Target range for cognitive health: 8–12%. Most people test between 4–5%. Correcting omega-3 deficiency with high-quality triglyceride-form fish oil typically takes 3–6 months at therapeutic doses — but the neuroinflammation reduction it produces creates a dramatically better environment for every other cognitive intervention to work in.
OmegaQuant (omegaquant.com) offers an at-home finger-prick test that is the gold standard for consumer omega-3 testing. Results in 2–3 weeks. Order before starting your cognitive protocol and retest at 3 months to confirm correction.
Nasal Spray Delivery — The CNS Shortcut
SS-31 and Selank are both available as nasal spray formulations — delivering compounds directly to the CNS, bypassing the blood-brain barrier.
The blood-brain barrier (BBB) is a selective filter that prevents most compounds from entering the brain from circulation. Nasal spray delivery bypasses this barrier entirely — compounds absorbed through the olfactory epithelium travel directly along olfactory nerves into the CNS, achieving higher brain concentrations faster than systemic injection.
Delivers the mitochondria-targeted peptide directly to neuronal tissue. Particularly useful for acute cognitive performance needs — many practitioners use nasal spray pre-task for rapid focus enhancement. Injectable SubQ remains preferable for ongoing systemic mitochondrial support.
The most common delivery format for Selank. Produces rapid anxiolytic and nootropic effects within 15–30 minutes. Available as standard or nano-spray formulation — nano-spray provides enhanced mucosal absorption and faster onset.
The Cognitive Stack — How It All Fits Together
Each compound in the stack addresses a different layer of the cognitive decline cascade.
Methylene Blue + SS-31 restore mitochondrial ATP production. This is the non-negotiable foundation. Without adequate cellular energy, no other cognitive intervention performs optimally.
Omega-3 correction (Omega Index guided) reduces neuroinflammation. BPC-157 addresses systemic inflammaging that crosses the blood-brain barrier. Combined, these reduce the inflammatory burden that impairs neuronal function.
Selank reduces cognitive anxiety and supports neuroplasticity. CAX supports neuronal metabolism and provides neuroprotection. Together they address the functional cognitive impairment once the energy and inflammation foundation is in place.
Epithalon restores deep sleep architecture — the glymphatic clearance window that removes neurotoxic waste and consolidates memory. Without this layer, cognitive gains from the other compounds are limited by insufficient overnight repair.
Anti-inflammatory diet, corrected omega-3 status, stress and autonomic nervous system regulation, and quality sleep are non-negotiable foundations. Peptide therapy amplifies a good foundation — it doesn't replace it. Labs to run before starting: Omega Index, hsCRP (inflammation), NAD+ levels, IGF-1 (growth hormone status).
Frequently Asked Questions
Brain fog and ADHD share significant symptom overlap — poor focus, distractibility, cognitive fatigue — but have different primary drivers. True ADHD involves dysregulation of dopamine and norepinephrine in specific attention circuits, often with a developmental component. Brain fog is typically more metabolic and mitochondrial in origin. In practice, many people have elements of both — and the mitochondrial support protocol (Methylene Blue + SS-31) is relevant to both, since mitochondrial dysfunction is increasingly recognized as a significant contributor to ADHD-type presentations.
For the metabolic and mitochondrial form of cognitive decline — which is the most common form in middle-aged adults — meaningful reversal of symptoms is frequently achievable, particularly when the protocol is started before irreversible neuronal loss has occurred. The earlier in the cognitive decline trajectory the intervention begins, the greater the potential for meaningful improvement.
Yes — it turns urine blue-green at therapeutic doses. This is expected, harmless, and temporary. It's a reliable indicator that you've reached a therapeutic dose level.
This is a critical question — particularly for Methylene Blue, which has mild MAO inhibitor properties. Combining Methylene Blue with serotonergic medications (SSRIs, SNRIs, tramadol, certain migraine medications) can potentially cause serotonin syndrome. This combination requires physician oversight and is generally avoided. Selank, CAX, SS-31, and Epithalon have lower interaction risk, but any change to a regimen involving psychiatric medications requires physician review before adding any new compound.
This guide is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Methylene Blue and peptide therapy for cognitive decline are used off-label. Always consult a qualified, licensed healthcare provider before beginning any protocol — particularly if taking serotonergic medications. InformedPeptides.com and its authors are not liable for actions taken based on the content of this page.
Tools & Calculators
Practical, free tools for anyone serious about peptide therapy — reconstitution math, dosing calculations, GLP-1 unit conversions, and stack-level analysis. Built to be used alongside your healthcare provider, not in place of one.
Available Now
Four free tools covering reconstitution math, dosing calculations, GLP-1 unit dosing, and stack-level analysis.
Before You Calculate
Our peptide profile pages cover the research, mechanisms, dosing ranges, and stacking strategies behind each peptide — so you know what the calculator is calculating.
Browse Peptide Profiles →What Is NAD+?
The coenzyme that powers every cell in your body — and declines dramatically with age.
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in every living cell. It's not a peptide in the traditional sense — it's a molecule your body produces and requires for hundreds of enzymatic reactions, including the ones that generate cellular energy, repair DNA damage, and regulate the proteins that control aging.
The problem is straightforward: NAD+ levels decline approximately 50% between the ages of 40 and 60. That decline isn't a minor inconvenience — it's one of the most consistent and well-documented biochemical changes in human aging, and it sits upstream of mitochondrial dysfunction, cognitive decline, metabolic slowdown, and impaired DNA repair.
Restoring NAD+ levels has become one of the most actively researched interventions in longevity medicine — with researchers including David Sinclair at Harvard identifying NAD+ restoration as a central pillar of any serious anti-aging protocol.
NAD+ doesn't work through a single mechanism — it's a foundational molecule that enables dozens of other biological processes. Restoring it doesn't just fix one thing; it improves the cellular environment across the board. This is why NAD+ is considered the most important molecule in longevity medicine by many researchers.
How Does NAD+ Work?
Four core mechanisms explain why NAD+ restoration has such broad and profound effects on aging.
NAD+ is the primary electron carrier in the mitochondrial electron transport chain — the process that converts food into ATP (cellular energy). Without adequate NAD+, mitochondria become inefficient, energy production drops, and cellular function across every tissue type declines.
Sirtuins are a family of 7 proteins that regulate aging, stress response, inflammation, and cellular repair. They are entirely NAD+-dependent — they cannot function without it. Declining NAD+ means declining sirtuin activity, which means accelerated aging across multiple biological pathways simultaneously.
PARP enzymes are the primary responders to DNA damage — they detect breaks and coordinate repair. PARP enzymes consume NAD+ as fuel for this process. As DNA damage accumulates with age, PARP activity increases, depleting NAD+ faster and creating a vicious cycle of declining repair capacity and accelerating damage.
NAD+ levels fluctuate with the circadian cycle — rising during the day to fuel activity and dropping at night to signal repair. The CLOCK genes that govern circadian rhythm are directly regulated by NAD+-dependent sirtuins. Disrupted NAD+ metabolism disrupts circadian timing, impairing sleep quality and the repair processes that depend on it.
What Is NAD+ Used For?
From energy restoration to cognitive performance — NAD+ has the broadest application profile of any longevity compound.
- Energy & Fatigue RecoveryThe most immediately noticeable effect for most people. Restoring NAD+ levels improves mitochondrial efficiency — resulting in more consistent energy, reduced afternoon fatigue, and better physical endurance. Effects are often noticeable within the first IV infusion.
- Cognitive Performance & Brain FogNAD+ is critical for neuronal energy production and neuroprotection. Declining NAD+ contributes directly to brain fog, cognitive slowing, and the memory changes associated with aging. Restoration consistently improves mental clarity, focus, and processing speed.
- DNA Repair & Genomic StabilityVia PARP enzyme support, NAD+ restoration improves the body's capacity to repair DNA damage — reducing the accumulation of mutations that drive cancer risk and cellular senescence.
- Metabolic Health & Body CompositionNAD+ supports insulin sensitivity, fat metabolism, and mitochondrial biogenesis — the process of creating new mitochondria. Relevant for anyone experiencing age-related metabolic slowdown, weight gain, or declining muscle mass.
- Addiction & Withdrawal SupportIV NAD+ has been used clinically in addiction medicine — particularly for alcohol and opioid withdrawal — where rapid NAD+ repletion appears to reduce withdrawal severity and craving intensity. One of the more established clinical applications.
- Longevity & Biological Age ReductionVia sirtuin activation, PARP support, and circadian regulation, NAD+ restoration addresses aging at a systems level. It is consistently identified as one of the highest-leverage interventions in longevity medicine.
How to Use NAD+
Three delivery methods — each with distinct use cases, bioavailability profiles, and practical considerations.
IV → SubQ → Oral. A loading series of 3–5 IV infusions to rapidly replete NAD+ levels, followed by subcutaneous NMN injections for ongoing maintenance, with oral NMN or NR on days between injections. This gives you the speed of IV, the bioavailability advantage of subQ, and the cost efficiency of oral as a daily base layer.
NAD+ in a Longevity Stack
NAD+ is the metabolic foundation that makes every other longevity intervention work better.
- +NAD+ + Epithalon — The most synergistic longevity pairing. Epithalon restores circadian rhythm and deep sleep — the conditions under which NAD+ synthesis is naturally upregulated. NAD+ supports the mitochondrial energy production that makes cellular repair during deep sleep possible. Together they address aging from two complementary directions: the cellular clock (telomeres) and cellular fuel (NAD+).
- +NAD+ + GHK-Cu — GHK-Cu's gene regulation includes antioxidant and inflammation-controlling genes that reduce the oxidative stress that depletes NAD+ via PARP activation. By reducing oxidative burden, GHK-Cu helps preserve NAD+ for energy production rather than constant damage repair.
- +NAD+ + BPC-157 — BPC-157 reduces systemic inflammation — one of the primary drivers of PARP over-activation and NAD+ depletion. Lower inflammatory burden means less NAD+ consumed by damage repair and more available for energy production and sirtuin activity.
- +NAD+ + Resveratrol / Quercetin — Resveratrol and quercetin are SIRT1 activators that work synergistically with NAD+ to enhance sirtuin activity. NAD+ provides the substrate; resveratrol amplifies the signal. A well-established pairing in the longevity research literature.
What to Look for When Sourcing NAD+ Precursors
Quality varies enormously between suppliers. These are the markers that separate research-grade product from underdosed supplements.
InformedPeptides may earn a commission on purchases made through affiliate links on this page. This never influences our editorial content or recommendations. We only recommend sources we have independently evaluated.
This page is for educational purposes only and does not constitute medical advice. NAD+ precursors and injectables should be discussed with a qualified healthcare provider. InformedPeptides does not prescribe, diagnose, or treat any medical condition. Always consult a qualified healthcare professional before beginning any protocol.
What Is Epithalon?
The most studied anti-aging peptide for telomere maintenance — backed by over 40 years of Russian clinical research.
Epithalon (also spelled Epitalon) is a synthetic tetrapeptide — just four amino acids: Alanine-Glutamic acid-Aspartic acid-Glycine (Ala-Glu-Asp-Gly). It was developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, where it has been the subject of continuous clinical research since the 1980s.
Epithalon is derived from Epithalamin — a natural peptide extract from the pineal gland. The pineal gland is the body's master regulator of circadian rhythm and the primary source of melatonin. As we age, pineal function declines — disrupting sleep architecture, reducing melatonin output, and impairing the hormonal signaling that coordinates cellular repair during deep sleep.
What distinguishes Epithalon from virtually every other anti-aging peptide is its direct effect on telomeres — the protective caps on chromosomes that function as the biological clock of aging. Epithalon is the only peptide with published human data demonstrating telomere elongation.
Epithalon is the only peptide with published human clinical data demonstrating actual telomere elongation — not just preservation. This places it in a category of its own among anti-aging compounds.
How Does Epithalon Work?
Four distinct mechanisms explain Epithalon's position as the anchor peptide in any serious longevity protocol.
Epithalon activates telomerase — the enzyme responsible for maintaining and elongating telomeres. In most adult somatic cells, telomerase is inactive, causing telomeres to shorten with each cell division. Epithalon reactivates this enzyme, slowing and in some cases reversing telomere shortening.
Epithalon restores the peptide signaling environment of the pineal gland — increasing melatonin output, normalizing circadian rhythm, and restoring the deep sleep architecture that declines with age. This mechanism alone has cascading effects on hormone production, cellular repair, and immune function.
Epithalon upregulates the expression of antioxidant enzymes — particularly superoxide dismutase (SOD) and glutathione peroxidase. These are the body's primary defenses against oxidative stress, one of the key drivers of telomere shortening and cellular aging.
Through pineal restoration, Epithalon normalizes the pulsatile release of growth hormone during deep sleep — the primary window for tissue repair, muscle maintenance, and metabolic regulation. This effect is particularly significant for adults over 40 experiencing age-related GH decline.
What Is Epithalon Used For?
From cellular longevity to sleep restoration — Epithalon addresses aging at its most fundamental level.
- Telomere Maintenance & LongevityThe primary application. Epithalon is the only peptide with published human data showing telomere elongation — making it the anchor compound in any serious longevity protocol. Used in courses of 10–20 days, 1–2 times per year.
- Deep Sleep RestorationOne of the most immediately noticeable effects. Users consistently report significantly improved sleep quality — particularly deeper, more restorative sleep — within the first course. This is the pineal restoration mechanism in action.
- Immune System RegulationEpithalon has demonstrated immunomodulatory effects in both animal and human studies — restoring immune function that declines with age and reducing markers of chronic inflammation.
- Cancer Risk ReductionLong-term Epithalon studies — some spanning 20+ years — have shown significant reductions in cancer incidence and overall mortality in treated populations. This is among the most striking findings in the entire peptide research literature.
- Perimenopause & Hormonal SupportEpithalon has shown particular benefit for women in perimenopause — normalizing hormonal cycling, improving sleep disruption, and reducing the severity of menopausal symptoms through its effect on the pineal-hypothalamic-pituitary axis.
- Retinal ProtectionOne of the more surprising research findings — Epithalon has demonstrated protective effects on retinal function in aging populations, potentially relevant to age-related macular degeneration risk reduction.
What Does the Research Say?
Epithalon has the most extensive human clinical research history of any peptide in the longevity space.
The Epithalon research base is unusual in the peptide space for two reasons: its depth and its duration. Professor Khavinson's team at the St. Petersburg Institute has conducted continuous research on Epithalon since the 1980s — including studies that have followed patients for over 20 years.
Key findings from the human clinical data include:
- Telomere ElongationPublished human data showing measurable telomere elongation in treated subjects — a finding that has not been replicated by any other peptide compound.
- Mortality ReductionLong-term studies showed approximately 33% reduction in overall mortality in Epithalon-treated populations compared to controls — a remarkable finding for any intervention.
- Cancer IncidenceSignificant reduction in cancer incidence observed across multiple long-term studies — consistent with the telomere maintenance and antioxidant gene expression mechanisms.
The majority of Epithalon's clinical research was conducted in Russia and published in Russian-language journals — which has historically limited its visibility in Western medical literature. This doesn't diminish the quality of the research; it explains why Epithalon remains less known in Western clinical practice than its evidence base warrants.
Epithalon in a Longevity Stack
Epithalon is consistently recommended as the anchor peptide in any longevity protocol.
- +Epithalon + NAD+ — The most synergistic longevity pairing. Epithalon restores circadian rhythm and sleep — the conditions under which NAD+ synthesis is upregulated. NAD+ supports the mitochondrial energy production that makes cellular repair during deep sleep possible. Together they address aging from two complementary directions: the cellular clock (telomeres) and cellular fuel (NAD+).
- +Epithalon + BPC-157 — A foundational anti-aging stack. BPC-157 addresses inflammaging — the chronic low-level inflammation that accelerates telomere shortening via oxidative stress. By reducing the inflammatory burden, BPC-157 preserves the telomere length that Epithalon works to maintain.
- +Epithalon + CJC-1295 + Ipamorelin — When IGF-1 testing shows growth hormone decline, adding a GH secretagogue stack amplifies the hormonal support that Epithalon initiates via pineal restoration. Particularly relevant for adults over 45 experiencing body composition changes or persistent fatigue.
- +Epithalon + GHK-Cu — The most complete anti-aging skin and longevity stack. Epithalon targets the chromosomal clock; GHK-Cu targets gene regulation, collagen synthesis, and the downstream tissue aging that telomere shortening produces. A complete anti-aging pairing for those prioritizing both longevity and aesthetic outcomes.
Quality Epithalon — What to Look For
Epithalon quality varies significantly between suppliers. These are the markers of a reputable source.
- ✓ Third-party Certificate of Analysis (CoA) available on request
- ✓ Purity ≥98% confirmed by HPLC testing
- ✓ Lyophilized (freeze-dried) powder — not pre-mixed solution
- ✓ Correct amino acid sequence confirmed (Ala-Glu-Asp-Gly)
- ✓ Cold-chain shipping with temperature indicator included
- ✗ No CoA available or supplier refuses to provide one
- ✗ Pre-reconstituted liquid Epithalon (highly unstable)
- ✗ Unusually low price — purity almost certainly compromised
- ✗ Shipped without cold-chain packaging in warm months
- ✗ No contact information or traceable company behind the product
IGF-1 (growth hormone status), hsCRP (inflammatory burden), and telomere length testing give you a meaningful baseline to track against. Retest telomere length after 12 months of consistent Epithalon use — this is the clearest objective marker of the peptide's effect on your specific biology.
This page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified, licensed healthcare professional before beginning any peptide protocol. InformedPeptides.com and its authors are not liable for actions taken based on the content of this page.





